Search Results - "Jarrard, David Frasier"

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial by Sweeney, Christopher, Chen, Yu-Hui, Carducci, Michael Anthony, Liu, Glenn, Jarrard, David Frasier, Eisenberger, Mario A., Wong, Yu-Ning, Hahn, Noah M., Kohli, Manish, Vogelzang, Nicholas J., Cooney, Matthew M., Dreicer, Robert, Picus, Joel, Shevrin, Daniel H., Hussain, Maha, Garcia, Jorge A., DiPaola, Robert S.

“…Abstract only LBA2 Background: Docetaxel (D) improves OS of men with mPrCa who have progressed on androgen deprivation therapy (ADT). We aimed to assess the…”
Get full text

A phase 2 study of 99m Tc-trofolastat chloride (MIP-1404) SPECT/CT to identify and localize prostate cancer (PCa) in high-risk patients (pts) undergoing radical prostatectomy (RP) and extended pelvic lymph node (ePLN) dissection compared to histopathology: An interim analysis by Slawin, Kevin Mark, Tenke, Peter, Joniau, Steven, Ellis, William J., Alekseev, Boris Y., Buzogány, Istvan, Mishugin, Sergey, Klein, Eric A., Stolz, Josef, Student, Vladimir, Matveev, Vsevolod, Karnes, R. Jeffrey, Jarrard, David Frasier, Yuh, Bertram E., Scherr, Douglas, Trabulsi, Edouard John, Babich, John, Stambler, Nancy, Armor, Thomas, Israel, Robert Joseph

“…Abstract only…”
Get full text

Impact on overall survival (OS) with chemohormonal therapy versus hormonal therapy for hormone-sensitive newly metastatic prostate cancer (mPrCa): An ECOG-led phase III randomized trial by Sweeney, Christopher, Chen, Yu-Hui, Carducci, Michael Anthony, Liu, Glenn, Jarrard, David Frasier, Eisenberger, Mario A., Wong, Yu-Ning, Hahn, Noah M., Kohli, Manish, Vogelzang, Nicholas J., Cooney, Matthew M., Dreicer, Robert, Picus, Joel, Shevrin, Daniel H., Hussain, Maha, Garcia, Jorge A., DiPaola, Robert S.

“…Abstract only…”
Get full text

A phase II study of 99m Tc-trofolastat (MIP-1404) SPECT/CT to identify and localize prostate cancer in high-risk patients undergoing radical prostatectomy (RP) and extended pelvic lymph node dissection (EPLND) compared to histopathology: An interim analysis by Slawin, Kevin Mark, Ellis, William J., Tenke, Peter, Joniau, Steven, Alekseev, Boris Y., Buzogány, Istvan, Mishugin, Sergey, Klein, Eric A., Karnes, R. Jeffrey, Scherr, Douglas, Yuh, Bertram E., Jarrard, David Frasier, Trabulsi, Edouard John, Stolz, Josef, Babich, John, Youssoufian, Hagop, Stambler, Nancy, Armor, Thomas, Israel, Robert Joseph

“…Abstract only 94 Background: Technetium (Tc99m) trofolastat (USANC) is a novel urea-based small molecule SPECT radiotracer with utility in imaging…”
Get full text